Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entrada Therapeutics Inc | TRDA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 12.36 | 04:05:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.36 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 10.62 - 18.44 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 12.36 | USD |
Entrada Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 415.31M | 33.60M | - | 129.01M | -6.69M | -0.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Entrada Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRDA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.83 | 14.03 | 11.8125 | 12.62 | 74,640 | 0.53 | 4.48% |
| 1 Month | 14.38 | 14.38 | 11.8125 | 12.94 | 80,129 | -2.02 | -14.05% |
| 3 Months | 14.70 | 15.565 | 11.35 | 13.22 | 78,991 | -2.34 | -15.92% |
| 6 Months | 13.59 | 17.58 | 10.7501 | 14.02 | 81,413 | -1.23 | -9.05% |
| 1 Year | 12.84 | 18.44 | 10.62 | 14.39 | 80,208 | -0.48 | -3.74% |
| 3 Years | 26.50 | 36.85 | 5.12 | 15.15 | 87,662 | -14.14 | -53.36% |
| 5 Years | 26.50 | 36.85 | 5.12 | 15.15 | 87,662 | -14.14 | -53.36% |
Entrada Therapeutics Description
| Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. |
